Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: South Africa Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20081
20091
20171
20211
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Eastern Cooperative Oncology Group2
Genzyme, a Sanofi Company2
Alliance for Clinical Trials in Oncology1
Arcus Biosciences, Inc.1
AstraZeneca1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Incyte Corporation1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung15
Lung Neoplasms7
Carcinoma, Renal Cell2
Melanoma2
Carcinoma1
Carcinoma, Hepatocellular1
Neoplasm Metastasis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.